Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.39 USD | +3.83% | -1.08% | +169.09% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
29/04 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+169.09% | 1.14B | |
+27.07% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.54% | 26.09B | |
-22.42% | 18.71B | |
+7.98% | 13.26B | |
+32.05% | 12.32B | |
+0.16% | 11.99B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : Morgan Stanley Adjusts Price Target on Cullinan Management to $40 From $38, Maintains Equal-Weight Rating